関連する実験動画
Updated: Feb 14, 2026

05:23
Motor Dual-Tasks for Gait Analysis and Evaluation in Post-Stroke Patients
Published on: March 11, 2021
2.9K
患者さんは下肢外傷後の歩行障害を自己認識できますか? 患者のケアへの関与を高めること
Tyler Forbes1, Joseph Cavataio2, Andrew Robinson1
1School of Medicine, Wayne State University, Detroit, MI 48201, USA.
Journal of clinical medicine
|February 13, 2026
まとめ
下肢のトラウマから回復している患者は,歩行異常を正確に特定することができます. の自己認識は,PROMISの低い身体機能スコアと相関し,リハビリテーションの関与を助けます.
科学分野:
- 整形外科 整形外科 整形外科
- リハビリテーション医学 リハビリテーション医学
- バイオメカニカルエンジニアリング
背景:
- 下肢のトラウマはしばしば歩行障害を引き起こし,患者の移動性と独立性に影響を及ぼします.
- 歩行異常に対する患者の自己認識は,リハビリテーションの遵守と機能的回復を改善することができます.
研究 の 目的:
- 整形外傷患者の歩行異常を正確に自己評価できるかどうかを判断する.
- 自己認識の歩行異常とPROMISの身体機能スコアとの相関性を調査する.
主な方法:
- レベル1の米国のトラウマセンターでの将来的な横断研究.
- 手術後の下肢トラウマを患った66人の患者が含まれており,外科医の助けを借りずに歩行することができました.
- 患者の自己認識の軟弱,PROMISの身体機能,および臨床歩行評価を評価した.
主要な成果:
- 患者は,歩行異常の存在 (95.92%) や欠如 (89.47%) を自己識別する上で高い精度を示した.
- PROMISの身体機能tスコアの有意な差は, (37.2) と (44.4) の患者と (44.4) の患者との間で観察されました.
- Limpの認識は,より悪い身体機能の結果と強く相関しています.
結論:
- 下肢のトラウマから回復している患者は,自分の歩行障害を認識する能力を持っている.
- 歩行異常の自己認識は,身体機能の低下と関連しており,リハビリテーションにおけるその重要性を強調しています.
- 回復のモニタリングに患者の関与を奨励することは,関与を強化し,臨床的決定を導くことができます.
さらに関連する動画
関連する概念動画
Patient-centered Care
3.1K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.1K
Ecological Disturbance
21.1K
An ecological disturbance is a temporary disruption in the environment resulting from abiotic, biotic, or anthropogenic factors, causing a pronounced change in an ecosystem. The impact of an ecological disturbance, which can depend on its intensity, frequency, and spatial distribution, plays a significant role in shaping the species diversity within the ecosystem.
21.1K
Drug Dosing: Geriatric Patients
279
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
279
Drug Dosing: Obese Patients
269
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269
Pharmacodynamics in Geriatric Patients: Effects of Age
241
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
241
Pharmacokinetics in Pediatric Patients: Drug Excretion
279
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
279

